Search

Your search keyword '"Holmberg SD"' showing total 235 results

Search Constraints

Start Over You searched for: Author "Holmberg SD" Remove constraint Author: "Holmberg SD"
235 results on '"Holmberg SD"'

Search Results

3. Transmission of AIDS from Blood Screened Negative for Antibody to the Human Immunodeficiency Virus

5. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study)

6. Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008.

7. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.

8. Circuit parties: sexual behaviors and HIV disclosure practices among men who have sex with men at the White Party, Palm Springs, California, 2003.

9. Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy.

10. Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons.

11. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.

12. HIV infection in women in the United States: status at the Millennium.

16. The global distribution of human immunodeficiency virus type 2 (HIV-2) infection

18. Migration patterns following HIV diagnosis among adults residing in the nonurban Deep South.

20. Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017.

21. Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis.

22. Trends in Diagnosed Chronic Hepatitis B in a US Health System Population, 2006-2015.

23. Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C.

24. Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS).

25. Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes.

26. Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States.

27. Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015.

28. Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States.

29. Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings.

30. The Predictive Value of International Classification of Disease Codes for Chronic Hepatitis C Virus Infection Surveillance: The Utility and Limitations of Electronic Health Records.

31. Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States.

32. Changing trends in complications of chronic hepatitis C.

33. A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C.

34. Comparison of ICD-9 Codes for Depression and Alcohol Misuse to Survey Instruments Suggests These Codes Should Be Used with Caution.

35. Hepatitis C Virus Infection Among Reproductive-Aged Women and Children in the United States, 2006 to 2014.

36. Long-term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B.

37. Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease.

38. Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study.

39. Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006-2013.

40. Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings.

41. Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2013.

42. Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma.

43. Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection.

44. Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS).

45. Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.

47. All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus.

48. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012.

49. Hepatitis A Infections Among Food Handlers in the United States, 1993-2011.

50. Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

Catalog

Books, media, physical & digital resources